We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+52.7%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$10.9M
Cap. Flow
-$10.3M
Cap. Flow %
-9.04%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
2
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$11.2M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$9.35M
3
PSNL icon
Personalis
PSNL
+$4.12M
4
CDNA icon
CareDx
CDNA
+$2.34M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$24.3M
2
TXG icon
10x Genomics
TXG
+$4.47M
3
GH icon
Guardant Health
GH
+$3.4M
4
QTRX icon
Quanterix
QTRX
+$2.67M
5
MXCT icon
MaxCyte
MXCT
+$2.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$37M 32.5%
291,094
-212,000
-42% -$24.3M
CDNA icon
2
CareDx
CDNA
$2.41B
$18.9M 16.59%
604,000
+94,000
+18% +$2.34M
EXAS
3
DELISTED
Exact Sciences
EXAS
$17.4M 15.29%
255,243
+197,900
+345% +$11.2M
AKYA
4
DELISTED
Akoya BioSciences
AKYA
$12.8M 11.24%
4,697,785
– –
ADPT icon
5
Adaptive Biotechnologies
ADPT
$4.07B
$11M 9.66%
+2,145,145
New +$9.35M
GH icon
6
Guardant Health
GH
$21.9B
$10.3M 9.1%
451,047
-120,000
-21% -$3.4M
PSNL icon
7
Personalis
PSNL
$1.69B
$5.38M 4.73%
+1,000,000
New +$4.12M
QTRX icon
8
Quanterix
QTRX
$140M
$1.02M 0.89%
78,393
-200,000
-72% -$2.67M
MXCT icon
9
MaxCyte
MXCT
$143M
– –
-603,937
Closed -$2.37M
TXG icon
10
10x Genomics
TXG
$8.1B
– –
-230,000
Closed -$4.47M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Blue Water Life Science Advisors held 10 positions worth $114M, up 11% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $10.3M in Q3 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was 10x Genomics, an estimated $4.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in Adaptive Biotechnologies worth $11M.

  • Blue Water Life Science Advisors's largest Q3 2024 buy was Adaptive Biotechnologies: 2,145,145 shares worth $11M.
  • Blue Water Life Science Advisors added most to Exact Sciences in Q3 2024, an estimated $11.2M increase.
  • Blue Water Life Science Advisors's biggest Q3 2024 reduction was Natera, cutting an estimated $24.3M.
  • Blue Water Life Science Advisors fully exited 10x Genomics in Q3 2024, selling an estimated $4.47M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $114M portfolio in Q3 2024.
  • Blue Water Life Science Advisors opened 2 new positions and closed 2 in Q3 2024.
  • Blue Water Life Science Advisors's portfolio value rose 11% quarter-over-quarter to $114M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.